The DOJ indictment does say that "Cytodyn director
Post# of 148155
Seems obvious that no matter what dose was decided on, Nader would have pushed way, way too hard to get the BLA submitted and would have misrepresented what actually was going on in his public statements, but the change to 700mg added so much more work that getting the BLA done even by the end of 2020 was probably impossible (not to mention the RO data issue).
Of course Nader fed us a line of bullshit about the change to 700mg, giving us his characteristic "something that had never been done before" line and saying that it was shortcut to getting the BLA completed.
I guess the question for the arbitrator would be, how do you untangle all of this? You have from at least late 2018 Nader imposing his massive force of will on meeting a delusional timeline and bulldozing everything in his path, and being enabled by Kazem, while employees on both sides object but are seemingly powerless to do anything about it. Is "the customer is always right" a basis for a ruling?